awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33837017-8DF2DD5D-80AC-408E-8C0E-9788FE749148
Q33837017-8DF2DD5D-80AC-408E-8C0E-9788FE749148
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33837017-8DF2DD5D-80AC-408E-8C0E-9788FE749148
Empagliflozin: a new sodium-glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.
P2860
Q33837017-8DF2DD5D-80AC-408E-8C0E-9788FE749148
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33837017-8DF2DD5D-80AC-408E-8C0E-9788FE749148
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c92fd65c7c94cb60c9504232abaf806b5d7d3729
P2860
The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose.